Tilray Unit Breckenridge Distillery Launches Paid Whiskey Club
Breckenridge Distillery, a subsidiary of Tilray Brands, has introduced a new quarterly membership program called the 2 Mile High Whiskey Club.
Stocks · News reference
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Raise Fiscal 2027 EBITDA Guidance
Tilray Brands is consolidating its Canadian cannabis cultivation and pre-roll production to improve efficiency and has raised the lower end of its fiscal 2027 Adjusted EBITDA guidance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Does Marijuana Rescheduling Really Help Tilray's Stock?
The U.S. government's reclassification of medical cannabis from Schedule I to Schedule III primarily benefits U.S.-based cannabis operators through lower tax bills, not Canadian producer Tilray. While rescheduling may be a step toward legalization, it doesn't guarantee future reform and could take years to materialize. Investors should be cautious about overreacting to rescheduling news, as Tilray's stock has historically surged temporarily on cannabis reform announcements only to decline to new lows.
Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?
Tilray announced a consolidation of its Canadian operations expected to generate $10 million in annual cost savings, leading to slightly raised adjusted EBITDA guidance for fiscal 2027 ($70-75 million vs. previous $68-75 million). However, the company continues to burn cash and faces challenges in the competitive Canadian cannabis market with low margins. Analysts remain cautious, suggesting investors take a wait-and-see approach as the improvements are insufficient to make the stock a compelling buy.
Tilray Brands Announces Consolidation of Canadian Cannabis Operations
Tilray Brands, Inc. is consolidating its Canadian cannabis production by transitioning cultivation and pre-roll operations from its Fenwick, Ontario facility to its sites in Masson, Quebec and Cayuga, Ontario.
Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
Tilray Brands has successfully transformed from a pure-play marijuana company into a diversified global consumer packaged goods company. In fiscal Q1 2027, beverage sales (largely beer) reached $101.5 million, up 82% year-over-year, now exceeding cannabis revenue of $56.1 million. The company achieved 71% growth in Europe, Middle East, and Africa (EMEA) markets, signaling successful international expansion beyond the U.S. marijuana market. While still unprofitable, Tilray's strategic pivot toward beverages and wellness positions it for potential sustainable profitability.
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Tilray Brands maintains a 4x revenue advantage over Canopy Growth, consistently generating $200+ million quarterly revenue compared to Canopy's $45-73 million. While both companies show year-over-year growth when comparing comparable quarters, Tilray demonstrates more stable and higher revenue levels. Canopy's latest Q4 2025 quarter ($73.3M) suggests potential momentum, but the revenue gap remains substantial.